Indian pharma exports are likely to register 17-20 per cent growth this fiscal, touching the USD 12 billion mark, a top official of the Pharmaceuticals Export Promotion Council (Pharmexcil) said.
India's largest export destination for pharma products is still the USA, followed by the UK, Germany, South Africa and Russia.
Segment-wise generics account for 58 per cent of total exports, active pharmaceutical ingredients (APIs) 40 per cent and ayurvedic/herbal/neutracuetical products the remaining 2 per cent, according to industry reports.
According to international consulting firm PricewaterhouseCoopers, by 2020, the size of the global pharmaceutical market is anticipated to grow to USD 1.3 trillion, with the E7 countries - Brazil, China, India, Indonesia, Mexico, Russia and Turkey -
India bank on young blood to come good in T20
CII asks oil ministry to withdraw price preference
India to get Euro200-bn loan from EU
AT&T to buy T-Mobile USA for $39 bn
Ministry to address Boxing Federation's grouses